<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
21.09.2017 21:19:02

Alnylam Pharmaceuticals: Bet or Fold?

A slew of analysts raised their price targets for Alnylam Pharmaceuticals after the drug maker's stock spiked  yesterday following the release of clinical trial data. But one analyst says its time to sell. Here's why.
Weiter zum vollständigen Artikel bei "Barrons stocks to watch today"